TAK1 inhibitor NG25 enhances doxorubicin-mediated apoptosis in breast cancer cells
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TAK1 inhibitor NG25 enhances doxorubicin-mediated apoptosis in breast cancer cells
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-09-07
DOI
10.1038/srep32737
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparison of cardiac events associated with liposomal doxorubicin, epirubicin and doxorubicin in breast cancer: a Bayesian network meta-analysis
- (2015) Norihiro Yamaguchi et al. EUROPEAN JOURNAL OF CANCER
- Targeting of TGF-β-activated protein kinase 1 inhibits chemokine (C-C motif) receptor 7 expression, tumor growth and metastasis in breast cancer
- (2015) Hui-Ling Huang et al. Oncotarget
- TAK1 control of cell death
- (2014) S R Mihaly et al. CELL DEATH AND DIFFERENTIATION
- Discovery of Type II Inhibitors of TGFβ-Activated Kinase 1 (TAK1) and Mitogen-Activated Protein Kinase Kinase Kinase Kinase 2 (MAP4K2)
- (2014) Li Tan et al. JOURNAL OF MEDICINAL CHEMISTRY
- MicroRNA-26b suppresses the NF-κB signaling and enhances the chemosensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB3
- (2014) Na Zhao et al. Molecular Cancer
- TAK1 inhibitor 5Z-7-oxozeaenol sensitizes neuroblastoma to chemotherapy
- (2013) Yihui Fan et al. APOPTOSIS
- Treatment of HER2-positive breast cancer
- (2013) Maria Cristina Figueroa-Magalhães et al. BREAST
- Immunotherapeutic approaches in triple-negative breast cancer: latest research and clinical prospects
- (2013) John Stagg et al. Therapeutic Advances in Medical Oncology
- TAK1 Inhibition Promotes Apoptosis in KRAS-Dependent Colon Cancers
- (2012) Anurag Singh et al. CELL
- Essential Role for IKKβ in Production of Type 1 Interferons by Plasmacytoid Dendritic Cells
- (2012) Eduardo Pauls et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
- (2012) Oktay Tacar et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- The IkappaB Kinase Family Phosphorylates the Parkinson’s Disease Kinase LRRK2 at Ser935 and Ser910 during Toll-Like Receptor Signaling
- (2012) Nicolas Dzamko et al. PLoS One
- RNAi Screening Identifies TAK1 as a Potential Target for the Enhanced Efficacy of Topoisomerase Inhibitors
- (2011) S. E. Martin et al. CURRENT CANCER DRUG TARGETS
- Modulation of Pancreatic Cancer Chemoresistance by Inhibition of TAK1
- (2011) Davide Melisi et al. JNCI-Journal of the National Cancer Institute
- A Cytosolic ATM/NEMO/RIP1 Complex Recruits TAK1 To Mediate the NF- B and p38 Mitogen-Activated Protein Kinase (MAPK)/MAPK-Activated Protein 2 Responses to DNA Damage
- (2011) Y. Yang et al. MOLECULAR AND CELLULAR BIOLOGY
- The E3 ligase Itch and deubiquitinase Cyld act together to regulate Tak1 and inflammation
- (2011) Neesar Ahmed et al. NATURE IMMUNOLOGY
- NF-κB regulates DNA double-strand break repair in conjunction with BRCA1–CtIP complexes
- (2011) Meta Volcic et al. NUCLEIC ACIDS RESEARCH
- NF- B in Cancer: A Matter of Life and Death
- (2011) B. B. Aggarwal et al. Cancer Discovery
- ATM- and NEMO-Dependent ELKS Ubiquitination Coordinates TAK1-Mediated IKK Activation in Response to Genotoxic Stress
- (2010) Zhao-Hui Wu et al. MOLECULAR CELL
- Shared Principles in NF-κB Signaling
- (2008) Matthew S. Hayden et al. CELL
- Tubocapsanolide A Inhibits Transforming Growth Factor-β-activating Kinase 1 to Suppress NF-κB-induced CCR7
- (2008) Mei-Ren Pan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now